Ranked on: #1 Most Active Corporate VCs of 2026 (Ranked) · #3 Top Health & Biotech Investors 2026 · #16 Most Active Growth Investors of 2026 (Ranked) · Get your badge →
Is this your firm? Get featured or correct your listing →
At a glance
Google Ventures (GV) appears in 17 funding rounds tracked by ValueAddVC since 2021, leading 4. Its most frequent sectors in these rounds are Health & Biotech and AI & Infrastructure, and its most recent tracked deal was Estuary Biotherapeutics' $93M Series A round (Oct 16, 2026). It co-invests most often with Accel, Kleiner Perkins and Tiger Global Management. ValueAddVC also tracks 1 fund managed by Google Ventures (GV).
Strategy
Stages
SeedSeries ASeries B
Sectors
AIHealthcareDeveloper ToolsInfrastructure
Geographies
USAMountain View, United States
Check size
$500K-$50MRecent changes
- Oct 16, 2026Oct 16, 2026Invested in Estuary Biotherapeutics (Series A, $93M) FierceBiotech
- Oct 15, 2026Oct 15, 2026Invested in OMass Therapeutics (Series C, $310M) ValueSpectrum
- Oct 13, 2026Oct 13, 2026Invested in Allara ($30M) AlleyWatch
- Oct 1, 2026Oct 1, 2026Invested in Armadin (Series B, $255.5M) TechCrunch
- Sep 30, 2026Sep 30, 2026Invested in Metaview (Series C, $60M) SiliconANGLE
Earlier changes (14)
- Sep 22, 2026Sep 22, 2026Invested in Snorkel AI (Series E, $350M) PR Newswire
- Sep 17, 2026Sep 17, 2026New fund: Google Ventures (GV) Fund II (target $50M) SEC EDGAR Form D
- Sep 9, 2026Sep 9, 2026Invested in Encoded Therapeutics (Series F, $275M) Encoded Therapeutics (Business Wire via BioSpace)
- Sep 5, 2026Sep 5, 2026Sectors updated: AI, Healthcare, Developer Tools, Infrastructure gv.com
- Aug 12, 2026Aug 12, 2026Invested in Blacksmith (Series B, $45M) PR Newswire
- Jun 17, 2026Jun 17, 2026Invested in Odyssey (Series B, $310M) Odyssey
- Jun 6, 2026Jun 6, 2026Invested in Flourish ($500M) TechFundingNews
- May 4, 2026May 4, 2026Invested in Sierra (Series E, $950M) CNBC
- Jan 26, 2026Jan 26, 2026Invested in Synthesia (Series E, $200M) techmorning.eu
- Oct 20, 2025Oct 20, 2025Invested in OpenEvidence (Series C, $200M) TechCrunch
- Sep 30, 2025Sep 30, 2025Follow-on: Invested in Vercel (Series F, $300M) Vercel
- Sep 26, 2025Sep 26, 2025Invested in Modular (Series C, $250M) SDxCentral
- May 16, 2024May 16, 2024Follow-on: Invested in Vercel (Series E, $250M) SiliconANGLE
- Nov 23, 2021Nov 23, 2021Invested in Vercel (Series D, $150M) Vercel
Funds
1| Fund | Vintage | Size | Strategy | Source |
|---|---|---|---|---|
| Google Ventures (GV) Fund II | 2026 | target $50M | Other | As of Sep 22, 2026SEC EDGAR Form D |
Portfolio
15 totalRecent Investment Activity
17Track record: led 4 and participated in 13 of 17 tracked venture rounds · 13 in the last 12 months · led 1 Series F, 1 Series E, 1 Series C
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | Estuary Biotherapeutics | Series A | Participated | $93M | — | RA CapitalLeadunverifiedDeep Track CapitalunverifiedGoogle Ventures (GV)unverifiedBiogen New VenturesUPMC EnterprisesPivotal bioVenture PartnersNational Kidney Foundation Innovation Fund+1 more | FierceBiotech |
| Oct 15, 2026 | OMass Therapeutics | Series C | Participated | $310M | — | Bain Capital Life SciencesLeadunverifiedForbionLeadunverifiedGoogle Ventures (GV)unverifiedNorthpond VenturesunverifiedSanofi VenturesunverifiedBritish Business BankunverifiedJanus Henderson InvestorsunverifiedNovo HoldingsSynconaOxford Science EnterprisesSV Health Investors+2 more | ValueSpectrum |
| Oct 13, 2026 | Allara | funding round | Led | $30M | — | Pulse story | |
| Oct 1, 2026 | Armadin | Series B | Participated | $255.5M | $2.5B | Andreessen HorowitzLeadunverifiedAccelLeadunverifiedBain Capital VenturesunverifiedRedpoint Venturesunverified8VCunverifiedGoogle Ventures (GV)unverifiedIn-Q-TelunverifiedKleiner PerkinsunverifiedMenlo VenturesunverifiedBallistic Ventures | Pulse story |
| Sep 30, 2026 | Metaview | Series C | Participated | $60M | — | Insight PartnersLeadunverifiedGoogle Ventures (GV)unverifiedIntrepid Growth PartnersunverifiedSeedcampunverifiedPluralunverifiedGaruda VenturesunverifiedVertex Ventures US | SiliconANGLE |
| Sep 22, 2026 | Snorkel AI | Series E | Participated | $350M | $3.5B | PR Newswire | |
| Sep 9, 2026 | Encoded Therapeutics | Series F | Led | $275M | — | Google Ventures (GV)LeadARCH Venture PartnersIllumina VenturesInvusJanus Henderson InvestorsRTW InvestmentsSoftBank Vision FundVenrockBraidwellFarallon Capital ManagementMatrix Capital ManagementNolan Capital | Encoded Therapeutics (Business Wire via BioSpace) |
| Aug 12, 2026 | Blacksmith | Series B | Participated | $45M | $550M | Pulse story | |
| Jun 17, 2026 | Odyssey | Series B | Participated | $310M | $1.45B | Odyssey | |
| Jun 6, 2026 | Flourish | funding round | Participated | $500M | $2.5B | TechFundingNews | |
| May 4, 2026 | Sierra | Series E | Led | $950M | $15.8B | CNBC | |
| Jan 26, 2026 | Synthesia | Series E | Participated | $200M | — | Google Ventures (GV)unverifiedNVenturesunverifiedAccelunverifiedKleiner PerkinsunverifiedNew Enterprise Associates (NEA)unverifiedAir Street CapitalunverifiedEvantic CapitalunverifiedHedosophiaunverifiedPSP GrowthMMC | techmorning.eu |
| Oct 20, 2025 | OpenEvidence | Series C | Led | $200M | — | TechCrunch | |
| Sep 30, 2025 | Vercel | Series F | Participated | $300M | $9.3B | AccelLeadWikipediaGICLeadWikipediaBlackRockunverifiedStepStone GroupunverifiedKhosla VenturesunverifiedSchrodersunverifiedAdams Street PartnersunverifiedGeneral CatalystunverifiedGoogle Ventures (GV)unverifiedSalesforce VenturesunverifiedTiger Global Managementunverified | Vercel |
| Sep 26, 2025 | Modular | Series C | Participated | $250M | $1.6B | SDxCentral | |
| May 16, 2024 | Vercel | Series E | Participated | $250M | $3.25B | SiliconANGLE | |
| Nov 23, 2021 | Vercel | Series D | Participated | $150M | $2.5B | GGV CapitalLeadunverifiedAccelunverifiedBedrock CapitalunverifiedCRVunverifiedGeodesic CapitalunverifiedGreenoaksunverifiedGoogle Ventures (GV)unverified8VCunverifiedSalesforce VenturesunverifiedSV AngelunverifiedTiger Global ManagementunverifiedFlex CapitalLatacora | Vercel |
Sector / Stage Activity
By sector (portfolio)
AI infra
4 · 27%
Biotech
3 · 20%
Enterprise SaaS
2 · 13%
Developer tools
2 · 13%
Healthtech
1 · 7%
Semiconductors
1 · 7%
Healthcare
1 · 7%
By stage (tracked rounds)
Series C
4 · 24%
Series E
4 · 24%
Series B
3 · 18%
Series F
2 · 12%
Series A
1 · 6%
Series D
1 · 6%
Co-Investors
12Similar Firms
overlapping sector, stage or regionValue Add Research
- Company Deep Dive · Oct 5, 2026Plaid: Inside the $8 Billion Bank-Linking API Behind Venmo, Robinhood, and ChatGPT
- AI & Technology · Sep 27, 2026Sierra's $950M Series E: Tiger Global and GV Bet on Agents
- VC & Investing · Sep 12, 2026Motive Funding: $1.3B Raise, IPO Withdrawn, $600M ARR
- Market & Trends · Jul 23, 2026$9B Wonder — Marc Lore's Series D & IPO Push
- VC & Investing · Jul 15, 2026Plaid IPO 2026: $8B Valuation (Feb 2026), No S-1 Yet
- VC & Investing · Jun 8, 2026Flourish: $500M at $2.5B, Bezos Brain-Inspired AI
- VC & Investing · May 1, 2026VC Internship Programs 2026: a16z, GC, Thrive Capital
Latest Pulse
- Sep 25, 2026OpenEvidence Raises $250M Led By Andreessen HorowitzOpenEvidence, the Miami-based clinical search platform for physicians, raised a new $250 million round led by hospital systems and Andreessen Horowitz.→
- Jun 30, 2026GV's Dave Munichiello on Qualcomm's Modular Deal, a Roughly 10x Return, and the AI Software ShiftGV general partner Dave Munichiello discussed Qualcomm's June 24 acquisition of AI infrastructure software startup Modular in a Crunchbase Q&A published June 30, describing a return of roughly 10x on GV's total dollars invested after leading Modular's Series A at a $155 million valuation with a $23 million check. Munichiello framed the deal as validation of a shift toward 'disaggregated inference' — software that lets AI workloads run efficiently across a mix of chips rather than locking into a single hardware vendor.→
- Jun 30, 2026Qualcomm's $3.9B Modular Buy Hands GV a 27x Return as Chipmakers Race to Own AI SoftwareQualcomm's roughly $3.9 billion acquisition of Modular -- the AI-software company founded by Swift and LLVM creator Chris Lattner -- has handed early backer GV a 27x return on its initial check, the firm's Dave Munichiello revealed this week. The deal is the clearest sign yet that the strategic battleground in AI is shifting from raw silicon to the software layer that makes chips usable, as Qualcomm bets it can challenge Nvidia's CUDA moat by owning the stack that runs models across CPUs, GPUs and AI accelerators.→
Google Ventures (GV) FAQ
What companies has Google Ventures (GV) invested in?
Google Ventures (GV)'s portfolio includes Estuary Biotherapeutics, OMass Therapeutics, Allara, Armadin, Metaview, OpenEvidence, and 9 more tracked companies.
Who does Google Ventures (GV) co-invest with most?
In the rounds Value Add tracks, Google Ventures (GV) most often invests alongside SV Angel (4 shared deals), Accel (3 shared deals), Kleiner Perkins (3 shared deals), 8VC (2 shared deals), Andreessen Horowitz (2 shared deals).
Sources & methodologyshow
Where these figures come from
- Odysseyprimary source1 fact
- PR Newswireprimary source1 fact
- PR Newswireprimary source1 fact
- SEC EDGAR Form Dprimary source1 fact
- Vercelprimary source1 fact
- Vercelprimary source1 fact
- CNBCmajor outlet1 fact
- FierceBiotechmajor outlet1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.